146 related articles for article (PubMed ID: 37317938)
1. Presenting characteristics and progression of pediatric-onset morphea: Interim analysis of a prospective registry.
Ng AT; Brandling-Bennett HA; Drolet BA; Siegel DH; Chiu YE
Pediatr Dermatol; 2023; 40(4):606-609. PubMed ID: 37317938
[TBL] [Abstract][Full Text] [Related]
2. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
[TBL] [Abstract][Full Text] [Related]
3. Pediatric morphea (localized scleroderma): review of 136 patients.
Christen-Zaech S; Hakim MD; Afsar FS; Paller AS
J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769
[TBL] [Abstract][Full Text] [Related]
4. Discordance of pediatric morphea treatment by pediatric dermatologists.
Tollefson MM; Chiu YE; Brandling-Bennett HA; Pope E
Pediatr Dermatol; 2018 Jan; 35(1):47-54. PubMed ID: 29165838
[TBL] [Abstract][Full Text] [Related]
5. Linear morphea overlying site of previous lichen aureus in a pediatric patient.
Johnston M; Benson P; Morley K
Pediatr Dermatol; 2019 Jul; 36(4):e91-e92. PubMed ID: 30994203
[TBL] [Abstract][Full Text] [Related]
6. Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease.
Sink JR; Chiu YE
Pediatr Dermatol; 2021 Sep; 38(5):1020-1031. PubMed ID: 34272748
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory arthritis in pediatric patients with morphea.
Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
[TBL] [Abstract][Full Text] [Related]
8. Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.
Kunzler E; Florez-Pollack S; Teske N; O'Brien J; Prasad S; Jacobe H
J Am Acad Dermatol; 2019 Jun; 80(6):1664-1670.e1. PubMed ID: 31005342
[TBL] [Abstract][Full Text] [Related]
9. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
[TBL] [Abstract][Full Text] [Related]
10. Upcoming treatments for morphea.
Wenzel D; Haddadi NS; Afshari K; Richmond JM; Rashighi M
Immun Inflamm Dis; 2021 Dec; 9(4):1101-1145. PubMed ID: 34272836
[TBL] [Abstract][Full Text] [Related]
11. Pediatric morphea.
Browning JC
Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
[TBL] [Abstract][Full Text] [Related]
12. Morphea and other localized forms of scleroderma.
Vasquez R; Sendejo C; Jacobe H
Curr Opin Rheumatol; 2012 Nov; 24(6):685-93. PubMed ID: 23018858
[TBL] [Abstract][Full Text] [Related]
13. Topical calcipotriene for morphea/linear scleroderma.
Cunningham BB; Landells ID; Langman C; Sailer DE; Paller AS
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):211-5. PubMed ID: 9704831
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of early immunosuppression in a morphea patient complicated with pulmonary interstitial fibrosis.
Chen B; Xue M; Yang J; Li M
Dermatol Ther; 2019 Sep; 32(5):e13061. PubMed ID: 31412161
[TBL] [Abstract][Full Text] [Related]
15. Localized scleroderma: a clinical study at a single center in Korea.
Noh JW; Kim J; Kim JW
Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units.
Virdi A; Patrizi A; Cambiaghi S; Diociaiuti A; El Hachem M; Schena D; Bassi A; Bonamonte D; Brazzelli V; Belloni Fortina A; Pepe P; DI Lernia V; Neri I
Ital J Dermatol Venerol; 2021 Aug; 156(4):446-454. PubMed ID: 33070566
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of morphea and lichen sclerosus and atrophicus in children.
Pope E; Laxer RM
Pediatr Clin North Am; 2014 Apr; 61(2):309-19. PubMed ID: 24636648
[TBL] [Abstract][Full Text] [Related]
18. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
Johnson W; Jacobe H
J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198
[TBL] [Abstract][Full Text] [Related]
19. Linear morphea with secondary mucinosis.
Khandpur S; Singh S; Sharma VK; Gupta R; Singh MK
Indian J Dermatol Venereol Leprol; 2009; 75(4):388-90. PubMed ID: 19584465
[TBL] [Abstract][Full Text] [Related]
20. An Evaluation of the Performance of Current Morphea Subtype Classifications.
Prasad S; Zhu JL; Schollaert-Fitch K; Torok KS; Jacobe HT
JAMA Dermatol; 2021 Apr; 157(4):1-8. PubMed ID: 33595618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
